Scott Bowerman, MD
Orthopaedic Surgery · Rome, GANPI 1124036876
Payments from drug & device makers
Across 35 payments — averaging $72.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$2K
- Amgen$97
- Pacira Therapeutics, Inc.$86
- Anika Therapeutics, Inc.$45
- Vertex$39
- Heron Therapeutics, Inc.$38
- plus $303 from 13 others
What the payments were for
- Consulting fees$1,92576%
- Food & beverage$60824%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 1 | $1,925 |
| Amgen(2 entities) | 6 | $97 |
| Pacira Therapeutics, Inc. | 6 | $86 |
| Anika Therapeutics, Inc. | 1 | $45 |
| Vertex | 1 | $39 |
| Heron Therapeutics, Inc. | 2 | $38 |
| Organogenesis Inc. | 2 | $34 |
| Smith+Nephew | 1 | $33 |
| Davol Inc. | 2 | $33 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Bioventus LLC | 2 | $27 |
| Trevena, Inc. | 1 | $25 |
| Arthrosurface Incorporated | 2 | $24 |
| Zimmer Biomet | 1 | $22 |
| Endo Pharmaceuticals Inc. | 1 | $18 |
| ERMI LLC | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Si-bone, Inc. | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $9 |
How this compares
$2,533 in reported general payments places this provider in the 40th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 55 | $2,621 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 110 | $715 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $464 |
| Ondansetron OdtOndansetron | 26 | $245 |
| Tramadol Hcl | 55 | $212 |
| Hydromorphone Hcl | 55 | $204 |
| Gabapentin | 30 | $174 |
| Cephalexin | 21 | $111 |
| Mupirocin | 21 | $110 |
| Oxycodone Hcl | 16 | $107 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $95 |
| Methylprednisolone | 12 | $93 |
| Meloxicam | 26 | $82 |
| Amoxicillin | 34 | $43 |
| Famotidine | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rome
- Brandon BushnellRome$370K
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
- Jon MinterAlpharetta$1.4M
- Tuan BuiLawrenceville$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.